Biokine Therapeutics Ltd.

RemeGen Ltd. has had many firsts in its specialist area of antibodies - including being the first Chinese firm in the field to gain a domestic approval, the first to sign a major out-licensing deal w

The proposed BIOSECURE Act is advancing through the US Congress after the Senate voted in favor of passing the associated bill, creating worry among industry insiders in China about the planned legisl

Chinese antibody-drug conjugate developers are making further inroads in global biotech dealmaking, with Chengdu-based Biokine Therapeutics Ltd. ’s US subsidiary recently inking a megadeal with Bris

Tel Aviv, Israel-based biotech BioLineRx Ltd. 's lead product candidate, a short peptide, BL-8040, that acts as a CXCR4 chemokine receptor antagonist, has improved long-term overall survival in a P